Search results
This High-Flying Stock Just Announced More Good News: Time to Buy? | The Motley Fool
The Motley Fool· 6 days agoThe biotech industry features many prominent companies that command plenty of attention on the...
Options Solutions LLC Reduces Stock Position in Colgate-Palmolive (NYSE:CL)
ETF DAILY NEWS· 16 hours agoThe institutional investor owned 8,605 shares of the company’s stock after selling 798 shares during...
Biotech Catapults On 'Unprecedented' Results For Gel-Based Drug
Investor's Business Daily· 2 days agoAfter three months, 79.6% of patients treated with UroGen Pharma's (URGN) drug had a complete...
Is It Time to Buy May's Worst-Performing Nasdaq Stocks?
Motley Fool via Yahoo Finance· 3 days agoMDB data by YCharts Could this biotech company triple in value? Exact Sciences (NASDAQ: EXAS) is...
Metals Exploration (LON:MTL) Stock Price Up 7.2%
ETF DAILY NEWS· 13 hours agoMetals Exploration plc (LON:MTL – Get Free Report)’s stock price shot up 7.2% on Thursday . The stock traded as high as GBX 4.30 ($0.05) and last traded ...
Auxier Asset Management Decreases Stock Holdings in McDonald’s Co. (NYSE:MCD)
ETF DAILY NEWS· 12 hours agoFinancial Engines Advisors L.L.C. increased its position in shares of McDonald’s by 47.2% during the 3rd quarter. Financial Engines Advisors L.L.C. now owns 1,191 shares of the fast-food giant ...
Walmart (NYSE:WMT) Stock Price Down 0.2% After Insider Selling
ETF DAILY NEWS· 22 hours agoSpecifically, major shareholder Alice L. Walton sold 1,132,123 shares of Walmart stock in a...
Will 374Water (NASDAQ:SCWO) Spend Its Cash Wisely?
Simply Wall St. via Yahoo Finance· 9 hours agoTaking a deeper dive, we've spotted 4 warning signs for 374Water you should be aware of, and 3 of them are potentially serious. Of course 374Water may...
Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy?
Motley Fool via Yahoo Finance· 6 days agoThis year, the biotech's stock is up by 33% thanks to new data from one of its pipeline programs...
Albemarle (NYSE:ALB) Sets New 52-Week Low After Analyst Downgrade
ETF DAILY NEWS· 2 days agoAlbemarle Co. (NYSE:ALB – Get Free Report) hit a new 52-week low on Friday after UBS Group lowered their price target on the stock from $132.00 to $124.00. Albemarle traded ...
